Supriya Lifescience Limited - Asset Resilience Ratio

Latest as of September 2025: 0.58%

Supriya Lifescience Limited (SUPRIYA) has an Asset Resilience Ratio of 0.58% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SUPRIYA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs69.80 Million

≈ $754.86K USD Cash + Short-term Investments

Total Assets

Rs12.03 Billion

≈ $130.10 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Supriya Lifescience Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Supriya Lifescience Limited total assets.

Liquid Assets Composition Over Time

This chart breaks down Supriya Lifescience Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read SUPRIYA total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs69.80 Million	0.58%
Total Liquid Assets	Rs69.80 Million	0.58%

Asset Resilience Insights

Limited Liquidity: Supriya Lifescience Limited maintains only 0.58% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Supriya Lifescience Limited Industry Peers by Asset Resilience Ratio

Compare Supriya Lifescience Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for Supriya Lifescience Limited (2018–2025)

The table below shows the annual Asset Resilience Ratio data for Supriya Lifescience Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	5.44%	Rs604.66 Million ≈ $6.54 Million	Rs11.12 Billion ≈ $120.29 Million	+1.64pp
2024-03-31	3.80%	Rs350.04 Million ≈ $3.79 Million	Rs9.21 Billion ≈ $99.63 Million	-5.98pp
2023-03-31	9.78%	Rs802.11 Million ≈ $8.67 Million	Rs8.20 Billion ≈ $88.71 Million	+1.73pp
2022-03-31	8.05%	Rs591.55 Million ≈ $6.40 Million	Rs7.35 Billion ≈ $79.46 Million	-1.58pp
2021-03-31	9.63%	Rs429.28 Million ≈ $4.64 Million	Rs4.46 Billion ≈ $48.21 Million	-12.12pp
2020-03-31	21.75%	Rs731.62 Million ≈ $7.91 Million	Rs3.36 Billion ≈ $36.38 Million	+17.53pp
2019-03-31	4.21%	Rs106.66 Million ≈ $1.15 Million	Rs2.53 Billion ≈ $27.37 Million	+1.82pp
2018-03-31	2.39%	Rs58.74 Million ≈ $635.25K	Rs2.45 Billion ≈ $26.54 Million	--

pp = percentage points

About Supriya Lifescience Limited

NSE:SUPRIYA India Biotechnology

Market Cap

$788.84 Million

Rs72.94 Billion INR

Market Cap Rank

#10043 Global

#499 in India

Share Price

Rs906.30

Change (1 day)

+0.63%

52-Week Range

Rs553.35 - Rs1052.50

All Time High

Rs1052.50